These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7222106)

  • 61. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
    Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
    Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The passage of 14C-labelled clofibrate through the liver [proceedings].
    Laker ME; Mayes PA
    Biochem Soc Trans; 1978; 6(3):583-4. PubMed ID: 669019
    [No Abstract]   [Full Text] [Related]  

  • 63. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
    Lee MJ; Gee P; Beard SE
    Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of fibric acid derivatives on biliary lipid composition.
    Palmer RH
    Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki.
    Nunes B; Carvalho F; Guilhermino L
    Chemosphere; 2004 Dec; 57(11):1581-9. PubMed ID: 15519403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
    Heller F; Harvengt C
    Eur J Clin Pharmacol; 1983; 25(1):57-63. PubMed ID: 6617725
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Covalent binding of styrene to DNA in rat and mouse.
    Cantoreggi S; Lutz WK
    Carcinogenesis; 1993 Mar; 14(3):355-60. PubMed ID: 8453710
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse effect of fenofibrate on branched-chain alpha-ketoacid dehydrogenase complex in rat's liver.
    Knapik-Czajka M; Gozdzialska A; Jaskiewicz J
    Toxicology; 2009 Dec; 266(1-3):1-5. PubMed ID: 19819289
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Metabolism of fenofibrate and fenofibric acid in vivo and in cultures of liver epithelial cells (author's transl)].
    Dulery B; Hammami M; Chessebeuf M; Legendre M; Noly P; Padieu P; Maume BF
    Nouv Presse Med; 1980 Dec; 9(49):3729-32. PubMed ID: 7208338
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
    Ito S; Tateno C; Tuda M; Yoshitake A
    Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells.
    Tsutsui T; Watanabe E; Barrett JC
    Carcinogenesis; 1993 Apr; 14(4):611-8. PubMed ID: 8472324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for the inhibition of platelet-derived growth factor induced rat smooth muscle cells DNA synthesis by fenofibric acid at the Go/G1 cell cycle level.
    Pascal M; Sepulchre C; Chazan JB; Majoie B
    Life Sci; 1983 Sep; 33(10):925-33. PubMed ID: 6888156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA-binding studies with 6BT and 5I: implications for DNA-binding/carcinogenicity and DNA-binding/mutagenicity correlations.
    Dashwood RH; Combes RD; Ashby J
    Mutat Res; 1988 Mar; 198(1):61-8. PubMed ID: 3127700
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of chronic administration of the peroxisome proliferator, clofibrate, on cytosolic acetyl-CoA hydrolase in rat liver.
    Nakanishi Y; Okamoto K; Isohashi F
    Biochem Pharmacol; 1993 Apr; 45(7):1403-7. PubMed ID: 8097090
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A simple and sensitive method for the determination of fibric acids in the liver by liquid chromatography.
    Karahashi M; Fukuhara H; Hoshina M; Sakamoto T; Yamazaki T; Mitsumoto A; Kawashima Y; Kudo N
    Biol Pharm Bull; 2014; 37(1):105-12. PubMed ID: 24389487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Investigation of the covalent binding of styrene-7,8-oxide to DNA in rat and mouse.
    Cantoreggi S; Lutz WK
    Carcinogenesis; 1992 Feb; 13(2):193-7. PubMed ID: 1740009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA-binding and disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in the rat.
    Dragsted LO; Frandsen H; Reistad R; Alexander J; Larsen JC
    Carcinogenesis; 1995 Nov; 16(11):2785-93. PubMed ID: 7586200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.